Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M106209200 on August 30, 2001

J. Biol. Chem., Vol. 276, Issue 44, 41112-41119, November 2, 2001
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/44/41112    most recent
M106209200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fukuda, M.
Right arrow Articles by Mikoshiba, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fukuda, M.
Right arrow Articles by Mikoshiba, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Formation of Crystalloid Endoplasmic Reticulum Induced by Expression of Synaptotagmin Lacking the Conserved WHXL Motif in the C Terminus

STRUCTURAL IMPORTANCE OF THE WHXL MOTIF IN THE C2B DOMAIN*

Mitsunori FukudaDagger §, Akitsugu Yamamoto, and Katsuhiko MikoshibaDagger ||

From the Dagger  Laboratory for Developmental Neurobiology, Brain Science Institute, RIKEN (The Institute of Physical and Chemical Research), 2-1 Hirosawa, Wako, Saitama 351-0198, the  Department of Physiology, Kansai Medical University, Moriguchi, Osaka 570-8506, and the || Department of Basic Medical Science, Division of Molecular Neurobiology, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan

Received for publication, July 3, 2001, and in revised form, August 23, 2001


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Synaptotagmin (Syt) is a family of type I membrane proteins that consists of a single transmembrane domain, a spacer domain, two Ca2+-binding C2 domains, and a short C terminus. We recently showed that deletion of the short C terminus (17 amino acids) of Syt IV prevented the Golgi localization of Syt IV proteins in PC12 cells and induced granular structures of various sizes in the cell body by an unknown mechanism (Fukuda, M., Ibata, K., and Mikoshiba, K. (2001) J. Neurochem. 77, 730-740). In this study we showed by electron microscopy that these structures are crystalloid endoplasmic reticulum (ER), analyzed the mechanism of its induction, and demonstrated that: (a) mutation or deletion of the evolutionarily conserved WHXL motif in the C terminus of the synaptotagmin family (Syt Delta C) destabilizes the C2B domain structure (i.e. causes misfolding of the protein), probably by disrupting the formation of stable anti-parallel beta -sheets between the beta -1 and beta -8 strands of the C2B domain; (b) the resulting malfolded proteins accumulate in the ER rather than being transported to other membrane structures (e.g. the Golgi apparatus), with the malfolded proteins also inducing the expression of BiP (immunoglobulin binding protein), one of the ER stress proteins; and (c) the ERs in which the Syt Delta C proteins have accumulated associate with each other as a result of oligomerization capacity of the synaptotagmin family, because the Syt IDelta C mutant, which lacks oligomerization activity, cannot induce crystalloid ER. Our findings indicate that the conserved WHXL motif is important not only for protein interaction site but for proper folding of the C2B domain.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Synaptotagmin I (Syt I)1 is an integral membrane protein of synaptic vesicles and a key molecule that regulates various steps of the synaptic vesicle cycle. It consists of a short intravesicular N terminus, a single transmembrane domain, a spacer domain, a C2A domain, a C2B domain, and a short C terminus (reviewed in Refs. 1-4). Each domain of Syt I has been shown to be crucial to expression of its functions and to have a distinct role in the synaptic vesicle cycle. For instance, the short C terminus (WHXL motif) of Syt I is involved in synaptic vesicle docking to the presynaptic plasma membrane, probably by binding to certain plasma membrane receptors, such as neurexins (5). The Ca2+ binding activity of the C2A domain is crucial for synaptic vesicle fusion to the presynaptic plasma membrane, because antibodies to the C2A domain that inhibits Ca2+/phospholipid or Ca2+/syntaxin binding to it interfere with the fusion step of secretory vesicles (6-11). The Syt I C2A domain is also important for neurite outgrowth and the axonal repair process (12-15). The C2B domain is involved in recycling of synaptic vesicles, probably by binding to the clathrin assembly protein AP-2 (16-18). The Ca2+-dependent self-oligomerization activity of the C2B domain has also been suggested to be involved in the fusion step of synaptic vesicles (19-22), because a Tyr-312 to Asn substitution in the C2B domain of Syt II, corresponding to the Drosophila AD3 mutation, impairs Ca2+-dependent self-oligomerization activity (20, 21), and inositol 1,3,4,5-tetrakisphosphate, a strong blocker of neurotransmitter release, inhibits Ca2+-dependent self-oligomerization activity of the C2B domain in vitro (20, 23-25). In addition, the phenotypes of Syt I mutants of Drosophila, Caenorhabditis elegans, and mice strongly support the above multiple functions of Syt I in the synaptic vesicle cycle (26-32).

Synaptotagmins are now known to form a large family of integral membrane proteins in both vertebrates and invertebrates (1, 33, 34), and it has been suggested that they regulate vesicular trafficking, because Syts II-XIII basically share the same domain structure with Syt I (i.e. a transmembrane domain, spacer domain, two C2 domains, and short C terminus). One of these domains, the N-terminal region of the C terminus, is highly conserved across phyla as well as different isoforms (Syts I-XIII), and it has been suggested to have functions common to the synaptotagmin family (5, 35). In our previous study, we showed that the WHXL motif in the C terminus of Syts I-XI is essential for plasma membrane association in PC12 cells and that the WHXL motif of Syt I regulates synaptic vesicle docking to the presynaptic plasma membrane in the squid giant synapse (5). In this study we report a novel role of the WHXL motif of the synaptotagmin family in proper folding of the molecules. We have shown by deletion and mutation analyses that the WHXL motif is essential for correct folding of the C2B domain (i.e. the WHXL motif is located in the beta -8 strand of the C2B domain rather than being an independent domain; see Fig. 3A). Expression of synaptotagmin mutants lacking the WHXL motif in cultured cells induced crystalloid endoplasmic reticulum (ER) structures (Refs. 36 and 37, and references therein) due to the abnormal folding of the proteins. Based on these results, we discuss the structural importance of the beta -8 strand of the C2 domains of synaptotagmins.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- Recombinant Taq DNA polymerase and restriction enzymes were obtained from Toyobo Biochemicals (Tokyo, Japan). Mouse monoclonal antibody (M2) and rabbit polyclonal antibody against FLAG peptide were obtained from Sigma Chemical Co. (St. Louis, MO) and Zymed Laboratories Inc. (San Francisco, CA), respectively. Horseradish peroxidase (HRP)-conjugated anti-T7 tag antibody and anti-T7 tag antibody-conjugated agarose were from Novagen (Madison, WI). HRP-conjugated anti-FLAG tag antibody was from Sigma. Anti-TGN38 antibody was from Transduction Laboratories (Lexington, KY). Anti-BiP (immunoglobulin binding protein, also called Grp78, a 78-kDa glucose-regulated protein) antibody was from StressGen Biotechnologies Corp. (Victoria, BC, Canada). All other chemicals were commercial products of reagent grade. Solutions were made up in deionized water prepared with an Elix10 water purification system and Milli-Q Biocel A10 system (Millipore Corp., Bedford, MA).

Plasmid Construction-- pEF-FLAG(or T7)-Syts I-XI, -Syts I-XIDelta C, -T7-N-Gly-Syt VIII, -T7-N-Gly-Syt IX, -T7-N-Gly-Syt VIIIDelta C, -T7-N-Gly-Syt IXDelta C, and -FLAG-Syt IVDelta C2B were essentially produced as described previously (5, 38-41). pEF-FLAG-Syt IVDelta 414-425, -Syt IVDelta 419-425, -Syt IVDelta 423-425, -Syt IVDelta 423-425(AAA), -Syt IVDelta 329-425, -Syt IVDelta 361-425, and -Syt IV(C2A)Delta C were constructed by the polymerase chain reaction using the following sets of primers with appropriate restriction enzyme sites (underlined) and/ or termination codons (boldface letters): 5'-GCACTAGTTCACTTAGCAATTTGTC(AT)CC-3' (Delta 414/419 primer; antisense; amino acid residues 413-418), 5'-GCACTAGTTCAGAGCATGTGCCACT-3' (Delta 423 primer; antisense; amino acid residues 418-422), 5'-GCACTAGTTCAGGCCATGGCCGCCTTAGCAATTTG-3' (Delta 423(AAA) primer; antisense; amino acid residues, 415-422), 5'-GCACTAGTCATTTGACGTAGGGATCTGAA-3' (Delta 329 primer, antisense; amino acid residues 322-328), 5'-GCACTAGTCAAAAGACAAACAGTTCATTG-3' (Delta 361 primer, antisense; amino acid residues 354-360), and 5'-GCACTAGTCACATTAACATTTTTCCATC-3' (C2ADelta C primer; antisense, amino acid residues 268-273).

pEF-FLAG-Syt IVDelta C(Delta 341-347) and -Syt IVDelta C(K341A, K342A,K346A) (KA) were essentially produced by means of two-step polymerase chain reaction techniques as described previously (25), using the following pairs of oligonucleotides: C2A primer, 5'-CGGATCCCAAGAGAAGCTGGGGACACT-3' and K/A primer, 5'-GCGTGCACTTCGCAACGTGAGTCGCCGCTTTAGAG-3' or Delta K primer, 5'-GCGTGCACTTAGAGATTCTCTTCTT-3' (left half), ApaLI primer, 5'-GCGTGCACTCCCAACGCAGTGTTC-3' and Delta C primer, 5'-GCACTAGTTCAGATCTCCTTCCAGTGCCC-3' (right half). pEF-FLAG-Syt IV(C2A-beta 1A3) and -Syt IV(C2A-Delta beta 1) were similarly constructed using the following pairs of mutagenic oligonucleotides: C2A-beta 1A3-5' primer, 5'-GACCAGAGCTGCAGCCCGGCCAGAAGACT-3' and C2A-beta 1A3-3' primer, 5'-TCTGGCCGGGCTGCAGCTCTGGTCTCTCT-3'; and C2A-Delta beta 1-5' primer, 5'-ACCGCGGCCAGAAGACTTCTT-3' and C2A-Delta beta 1-3' primer, 5'- CCGCGGTACAAACACGCTCACTGTGGTG-3'. The resulting Syt IV mutant fragments were subcloned into the NotI site of the modified pEF-BOS mammalian expression vector (24, 42). All constructs were verified by DNA sequencing using a Hitachi SQ-5500 DNA sequencer. Plasmid DNA was prepared using Wizard-mini preps (Promega, Madison, WI) or Qiagen (Chatsworth, CA) Maxi prep kits.

Immunocytochemistry-- Glass-bottom dishes (35 mm-dish, MatTek Corp.) were coated with collagen type IV (Becton Dickinson, Bedford, MA). PC12 cells (0.8-1 × 105 cells, the day before transfection) were cultured on these dishes in Dulbecco's modified Eagle's medium containing 10% horse serum and 10% fetal bovine serum at 37 °C under 5% CO2. Transfection was achieved by using the LipofectAMINE Plus reagent according to the manufacturer's instructions (Life Technologies Inc., Gaithersburg, MD). Three days after transfection, PC12 cells were fixed, permeabilized, and stained with both rabbit anti-FLAG antibody (1/1000 dilution) and anti-TGN38 mouse monoclonal antibody (1/500 dilution) or anti-BiP mouse monoclonal antibody (1/200 dilution), as described previously (43, 44). Immunoreactivity was analyzed with a fluorescence microscope (TE300, Nikon, Tokyo, Japan) attached to a laser confocal scanner unit CSU 10 (Yokogawa Electric Corp., Tokyo, Japan) and HiSCA charge-coupled device camera (C6790, Hamamatsu Photonics, Hamamatsu, Japan). Images were pseudo-colored and superimposed with Adobe Photoshop software (Version 4.0).

Electron Microscopy-- PC12 cells cultured on collagen-coated plastic coverslips (Sumitomo Bakelite, Tokyo, Japan) were fixed with 2.5% glutaraldehyde in 0.1 M sodium phosphate buffer (pH 7.4) for 2 h. After washing in the buffer, cells were post-fixed in 1% OsO4 in 0.1 M sodium phosphate buffer (pH 7.4) for 1 h. The cells were then washed in distilled water, incubated with 50% ethanol for 10 min, and stained with 2% uranyl acetate in 70% ethanol for 2 h. The cells were further dehydrated with a graded series of ethanol and embedded in epoxy resin. Ultra-thin sections were doubly stained with uranyl acetate and lead citrate and then examined under a Hitachi H7000 electron microscope.

Synaptotagmin Oligomerization Assay-- pEF-T7-Syts and pEF-FLAG-Syts were cotransfected into COS-7 cells (5 × 105 cells the day before transfection/10-cm dish) as described previously (45). Three days after transfection, cells were harvested and homogenized in 50 mM HEPES-KOH, pH 7.2, 250 mM NaCl, 0.1 mM phenylmethylsulfonyl fluoride, 10 µM leupeptin, and 10 µM pepstatin A. The proteins expressed were solubilized with 1% Triton X-100, immunoprecipitated with anti-T7 tag antibody-conjugated agarose, and analyzed by 7.5% SDS-polyacrylamide gel electrophoresis (PAGE) as previously described (38, 40, 45). Co-immunoprecipitated FLAG-Syts were first detected with HRP-conjugated anti-FLAG antibody (1/10,000 dilution). The same blots were stripped and reprobed with HRP-conjugated anti-T7 tag antibody to ensure loading of the same amounts of T7-Syt proteins (1/10,000 dilution).

Endoglycosidase H Digestion of T7-N-Gly-synaptotagmins-- PC12 cells (4 × 106 cells, the day before transfection) were cultured on 10-cm collagen type I-coated dishes (Becton Dickinson) in Dulbecco's modified Eagle's medium containing 10% horse serum and 10% fetal bovine serum at 37 °C under 5% CO2. Transfection was achieved by using the LipofectAMINE Plus reagent as described above. Immunoprecipitation of T7-Syts by anti-T7 tag antibody-conjugated agarose was performed as described previously (38, 39, 45). The beads were resuspended in 30 µl of the buffer (50 mM sodium acetate, pH 5.3, 0.1% SDS, 0.5% IGEPAL CA-630 (Sigma Chemical Co.), 0.1 mM phenylmethylsulfonyl fluoride, 10 µM leupeptin, and 10 µM pepstatin A) and then divided into two microtubes. After denaturation by boiling for 3 min and cooling to 37 °C, 5 milliunits of endoglycosidase H (Roche Diagnostics, Mannheim, Germany) was added to one tube, and the mixtures were incubated for 1 h at 37 °C (41). Reactions were stopped by adding SDS sample buffer and boiling for 3 min. Proteins were subjected to 10% SDS-PAGE and immunoblotting with HRP-conjugated anti-T7 tag antibody as described previously (38-40).

Trypsin Digestion of Recombinant C2B Domain of Synaptotagmin IV-- Syt IV-C2BDelta 423-425 and mutant Syt IV-C2BDelta 423-425(AAA) fused to glutathione S-transferase (GST) were prepared by a standard method (24, 46), and after incubating 4 µg of GST fusion proteins in 10 mM Tris-HCl, pH 7.5, and 100 mM NaCl with 1 ng/µl trypsin (Sigma Chemical Co.) for 0-30 min at 25 °C, the reactions were stopped by addition of SDS sample buffer and boiling for 3 min. Samples were then analyzed by 12.5% SDS-PAGE and staining with Coomassie Brilliant Blue R-250.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Induction of Crystalloid ER by Expression of Synaptotagmin IV Lacking the WHXL Motif-- In the course of determining the Golgi localization signal of Syt IV in PC12 cells, we found that the deletion of the short C terminus (amino acid residues 409-425) prevented the Golgi localization of Syt IV and induced large granular structures of various sizes (Ref. 41 and Fig. 1, A and C). Interestingly, these granular structures in which Syt IVDelta C proteins had accumulated were easily identified on light-field micrographs (arrowheads in Fig. 1D). Because they were also positive with anti-BiP antibody, a marker for the ER, we suspected that they represented crystalloid ER (36, 37; see also Fig. 1, E-G, arrows). Electron microscopic observation of the cells expressing Syt IVDelta C revealed a unique membranous structure characteristic to "crystalloid ER" (36, 37), which is composed of tightly packed smooth ER cisternae (Fig. 3H, arrowheads) or tubules (Fig. 3H, arrows). The crystalloid ER was occasionally continuous to rough ER cisternae (Fig. 3H, small arrows).


View larger version (62K):
[in this window]
[in a new window]
 
Fig. 1.   Deletion of the short C terminus prevents Golgi localization of synaptotagmin IV and induces crystalloid ER. FLAG-Syt IV (A, B) and -Syt IVDelta C (C-H) proteins were expressed in PC12 cells as described under "Experimental Procedures." PC12 cells were fixed, permeabilized, and stained with anti-FLAG rabbit antibody (green in A, C, E, and G) and anti-BiP antibody (red in F and G). B and D are light-field micrographs of A and C, respectively. The inset in D is a superposition of C and D. Note that the granules could be detected by light-field microscopy (arrowheads in D) and that they colocalized with BiP (arrows in E-G). H, electron micrograph of PC12 cells expressing FLAG-Syt IVDelta C proteins. The crystalloid ER is composed of tightly packed smooth ER cisternae (arrowheads in H) or tubule (arrows in H). The crystalloid ER was occasionally continuous to rough ER cisternae (small arrows in H). DCV, dense-core vesicle; RER, rough ER; M, mitochondria. Scale bars in G and H indicate 20 µm and 500 nm, respectively.

To identify the amino acid residues responsible for the induction of crystalloid ER by expression of Syt IVDelta C, we constructed various additional C-terminal deletion mutants (Fig. 2A). After deletion of more than seven amino acids from the C terminus (FLAG-Syt IVDelta 419-425), we observed mis-sorting of Syt IV mutant proteins and formation of crystalloid ER of various sizes within the cell body (Fig. 2C, Delta 414-425, Delta 419-425 in green and TGN38 in red), but deletion of three amino acids did not affect the Golgi localization of Syt IV (Fig. 2C, Delta 423-425, arrowheads). When the conserved WHML (amino acids 419-422) sequences were mutated to AAMA, expression of FLAG-Syt IVDelta 423-425(AAA) induced granule formation similar to that of Syt IVDelta C (Fig. 2C). Thus, the WHXL sequences are in some way related to the formation of crystalloid ER and the Golgi localization of Syt IV. Because deletion of the whole C2B domain (FLAG-Syt IVDelta C2B) attenuated the crystalloid ER formation induced by deletion of the C terminus (Delta C) and Syt IVDelta C2B proteins were localized in the Golgi (Fig. 2C, arrowhead in center panel), the C2B domain was further systematically deleted from the C terminus, and the putative effector domain of the C2B domain was deleted or mutated to clarify the relationship between the C2B domain and the WHXL sequences (Fig. 2C) (25, 47, 48). These mutations and deletions, however, failed to restore the Golgi localization of Syt IVDelta C proteins (Fig. 2C, Delta 329-425, Delta 361-425, Delta C(341-347), and Delta C(KA) in green and TGN38 in red).


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 2.   Expression of synaptotagmin IV lacking the WHXL motif induces crystalloid ER in PC12 cells. A, schematic representation of the C-terminal mutants of Syt IV. B, schematic representation of the C2B deletion mutants of Syt IV. FLAG tags, the transmembrane domain (TM), and two C2 domains are represented by black boxes, open boxes, and hatched boxes, respectively. The double dots and dashes indicate amino acids identical to the top sequence and deletions, respectively. Amino acid substitutions are indicated by the single-letter amino acid code below the wild-type sequences (bottom lines in A and B). Amino acid numbers, except for the FLAG tag sequence, are given on the right. C, subcellular localization of the C-terminal and C2B deletion mutants of FLAG-Syt IVDelta 414-425, -Syt IVDelta 419-425, -Syt IVDelta 423-425, -Syt IVDelta 423-425(AAA), -Syt IVDelta C2B, -Syt IVDelta 329-425, -Syt IVDelta 361-425, -Syt IVDelta C(Delta 341-347), and -Syt IVDelta C(KA) were expressed in PC12 cells as described under "Experimental Procedures." PC12 cells were fixed, permeabilized, and stained with both anti-FLAG rabbit (green) and anti-TGN38 antibodies, a marker for the TGN (red). Note that only FLAG-Syt IVDelta 423-425 and -Syt IVDelta C2B overlapped well with TGN38 (arrowheads). Scale bar indicates 20 µm.

The Formation of Crystalloid ER Structures by Expression of Other Synaptotagmins Lacking the WHXL Motif-- The WHXL motif is highly conserved among the C-terminal type tandem C2 proteins, including the synaptotagmin family, rabphilin-3A, the Doc2 family, and the Slp family (synaptotagmin-like protein) (35, 49, 50) and was proposed to be an independent domain (4), because the short C terminus of these proteins interacts with polymorphic plasma membrane receptors, neurexins, in vitro (33, 49, 51-54). However, recent demonstration of the three-dimensional structure of the C2B domain of Syt III (55) and rabphilin-3A (56) has provided strong evidence against this notion, and the WHXL motif must be a part of the C2B domain rather than an independent domain. The C2B domain of Syt III is composed of an eight-stranded anti-parallel beta -sandwich structure consisting of four-stranded beta -sheets (anti-parallel pairing of beta -1 and beta -8, beta -2 and beta -5, beta -3 and beta -4, and beta -6 and beta -7 strands), the same as the Syt I C2A domain (reviewed in Ref. 57; see also Fig. 3A). The major difference between the C2A and C2B domains is that the C2B domain contains an additional alpha -helix region between the beta -7 and beta -8 strands (Fig. 3A). It should be noted that this alpha -helix region was previously thought to be a beta -8 strand of the C2B domain (Fig. 3B, broken arrow) (55, 56). Based on these findings, together with the fact that crystalloid ER is induced by expression of malfolded proteins (58), we hypothesized that deletion of a portion of the beta -8 strand (the WHXL motif) of the C2B domain destabilizes the C2B domain structure (i.e. the C2B domain lacking the WHXL motif cannot fold correctly) and induces the crystalloid ER structures.


View larger version (42K):
[in this window]
[in a new window]
 
Fig. 3.   Proposed structure of the C2B domain of synaptotagmins. A, schematic representation of the C2B domain of synaptotagmin IV (modified from Ref. 57). The arrows represent eight strands of the C2B domain (beta 1-beta 8). Three loops are formed at the tip of the beta -sandwich structure, and two of them are involved in Ca2+-binding in the C2A domain of Syt I (57). The overall structure of the C2B domain is quite similar to the C2A domain, but an additional alpha -helix is present between the beta -7 and beta -8 strands in the C2B domain (55, 56). Note that the N-terminal beta -1 strand and C-terminal beta -8 strand form a pair to create an anti-parallel beta -sheet. B, sequence alignment of the beta -1 and beta -8 strands (solid arrows) and the alpha -helix (broken line) of the Syts I-XIII C2B domains (33, 38, 55). Asterisks indicate the conserved WHXL motif (5). The number signs indicate the positions of amino acid substitutions (GEL-to-AAA) in the Syt IV(C2B-beta 1A3) mutant (see also Fig. 5A). Note that the alpha -helix region was previously thought to be a beta -8 strand of the C2B domain by analogy with the C2A domain (beta 8', broken arrow at the bottom) (57).

If this hypothesis were true, deletion of the beta -8 strand of the C2B domain of other synaptotagmin isoforms should induce the same crystalloid ER structures, because the WHXL motif is highly conserved in the synaptotagmin family (Fig. 3B). As expected, expression of Syts I-XIDelta C proteins also induced crystalloid ER-like structures in PC12 cells (Fig. 4A, arrowheads and data not shown), although the appearance of the crystalloid ER-like structures differs according to the Syt isoform (5-50% of total cells). Interestingly, expression of an Syt IDelta C mutant that lacks oligomerization activity (Fig. 4B; Syt IDelta spacer/Delta C) (59) failed to induce crystalloid ER-like structures, despite the absence of the WHXL motif (Fig. 4A, right upper panel).


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 4.   Induction of crystalloid ER-like structures by C-terminal truncation of the synaptotagmin family. A, FLAG-Syt IDelta C, -Syt IDelta spacer/Delta C, -Syt VIDelta C, and -Syt XIDelta C were expressed in PC12 cells as described under "Experimental Procedures." PC12 cells were fixed, permeabilized, and stained with anti-FLAG antibody. Note that the crystalloid ER-like structures were induced by expression of Syt IDelta C, Syt VIDelta C, and Syt XIDelta C (arrowheads), but not Syt IDelta spacer/Delta C, which did not exhibit Ca2+-independent oligomerization activity (59) (see also B). Scale bar indicates 20 µm. B, oligomerization activity of Syt IDelta C (or Syt IDelta spacer/Delta C). pEF-T7-Syt I and FLAG-Syt IDelta C (or -Syt IDelta spacer/Delta C) were co-transfected into COS-7 cells. Association between T7-Syt I and FLAG-Syt IDelta C (or -Syt IDelta spacer/Delta C) was evaluated by immunoprecipitation with anti-T7 tag antibody-conjugated agarose (IP) as described previously (38, 45). Top panel, total expressed FLAG-Syt IDelta C and -Syt IDelta spacer/Delta C (1/40 volumes of reaction mixtures; input) used for immunoprecipitation. Middle panel, co-immunoprecipitated FLAG-tagged proteins (blot: anti-FLAG). Lower panel, immunoprecipitated T7-Syt I (blot: anti-T7). The arrow indicates the SDS-resistant dimer of Syt IDelta C. The positions of the molecular weight (Mr) markers (×10-3) are shown on the left.

Next, we focused on the beta -1 strand of the C2B domain of Syt IV, because the N-terminal beta -1 strand and C-terminal beta -8 strand pair to form anti-parallel beta -sheets (Fig. 3A). Deletion of the beta -1 strand of the C2B domain of Syt IV (C2B-Delta beta 1, Fig. 5) or substitution of AAA for the conserved G(E/D)(L/I) sequence of the beta -1 strand of Syt IV (C2B-beta 1A3) induced crystalloid ER-like structures, the same as Syt IVDelta C, suggesting that pairing of the beta -1 and beta -8 strands is important for proper folding of the C2B domain. These results, together with the fact that the basic structure of both the C2A and C2B domains is the same (55-57), prompted to us to examine whether deletion of the beta -8 strand of the C2A domain would also induce crystalloid ER. As expected, expression of Syt IV(C2A)Delta C proteins induced the same crystalloid ER-like structures (Fig. 5B, top panel).


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 5.   Expression of synaptotagmin IV lacking the beta -1 strand of the C2B domain or beta -8 strand of the C2A domain induces crystalloid ER-like structures in PC12 cells. A, schematic representation of the beta -1 (or beta -8) strand-mutants of Syt IV. B, subcellular localization of the beta -1 and beta -8 strand-mutants of Syt IV. FLAG-Syt IV(C2A)Delta C, -Syt IV(C2B-Delta beta 1), and -Syt IV(C2B-beta 1A3) were expressed in PC12 cells as described under "Experimental Procedures." PC12 cells were fixed, permeabilized, and stained with anti-FLAG antibody. In all cases, crystalloid ER-like structures were induced. Scale bar indicates 20 µm.

Incomplete Post-translational Modifications of Syt Delta C Proteins in PC12 Cells-- Vertebrate Syts I and II contain a single N-glycosylation site in the N-terminal intravesicular domain (24, 39, 41, 51, 60), and the N-liked sugars are further converted to complex oligosaccharides in the Golgi of PC12 cells (41). Because the dense-core vesicles where Syt I is abundant are thought to be derived from the TGN (trans-Golgi network) in PC12 cells, we decided to investigate whether Syt IDelta C proteins pass through the Golgi and TGN or are only retained in the ER. To do so, we used endoglycosidase H, which cleaves unmodified N-linked sugars but not complex oligosaccharides (41). The N-linked sugars of the wild-type T7-Syt I, -Syt II, -N-Gly-Syt VIII, and -N-Gly-Syt IX in PC12 cells were further modified and were resistant to endoglycosidase H treatment, whereas the mutant proteins (Syt Delta C) were mostly sensitive to endoglycosidase H (Fig. 6, A and B). By contrast, the N-linked sugars of both the wild-type and mutant proteins were cleaved by N-glycosidase F, which cleaves all N-linked sugars, regardless of modifications (data not shown). These results indicate that the newly synthesized Syt Delta C proteins had been correctly inserted into the ER membrane and had been retained in the ER without being transported to the Golgi, where complex modification occurs.


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 6.   Analysis of T7-Syts IDelta C, IIDelta C, T7-N-Gly-Syts VIIIDelta C, and IXDelta C by endoglycosidase H treatment. A, treatment of T7-Syt I, -Syt IDelta C, -Syt II, and -Syt IIDelta C with endoglycosidase H (endo H). T7-Syts were expressed in PC12 cells and immunoprecipitated by anti-T7 tag antibody-conjugated agarose as described previously (38, 45). Immunoprecipitants were exposed to or not exposed to glycosidase, subjected to 10% SDS-PAGE, and then analyzed by immunoblotting with HRP-conjugated anti-T7 tag antibody. Note that Syts I and II were resistant to endoglycosidase H (broken boxed), but Syts IDelta C and IIDelta C were highly sensitive to endoglycosidase H. The results shown are representative of three independent experiments. The positions of the Mr markers (×10-3) are shown on the left. B, proportion of the endoglycosidase H-resistant band of T7-Syts I, II, T7-N-Gly-Syts VIII, IX (black columns), IDelta C, IIDelta C, T7-N-Gly-Syts VIIIDelta C, and IXDelta C (white columns). Immunoreactive bands in A were captured by Gel Print 2000i/VGA (Bio Image) and quantified by Basic Quantifier Software (version 1.0) (Bio Image). Columns indicate the proportion of endoglycosidase H-resistant bands (i.e. the proportion of proteins that were modified in the Golgi). Bars indicate the S.D. of three independent experiments.

Essential Role of the WHXL Motif in the C2B Domain Structure-- Finally, we investigated whether the WHXL motif is essential for the proper folding of the C2B domain biochemically by monitoring its sensitivity to proteolysis. If the above hypothesis were correct, mutation of the WHXL motif to AAXA would cause it to fail to form a stable C2 domain structure by disrupting the pairing of the beta -1 and beta -8 strands, and the mutant proteins should be more sensitive to proteinase than the wild-type proteins. When the GST-Syt IV-C2BDelta 423-425 proteins (including the WHXL motif) were treated with low concentrations of trypsin, they were rapidly cut into two pieces at the fusion site between GST (open arrowheads) and Syt IV-C2B (asterisk in Fig. 7, upper panel). The C2BDelta 423-425 proteins (including the WHXL motif) were highly resistant during 30 min of incubation at this concentration of trypsin, whereas the mutant C2B domains were degraded within 10 min. Thus, the WHXL motif was indeed found to be essential for the packed C2B domain structure.


View larger version (53K):
[in this window]
[in a new window]
 
Fig. 7.   Limited proteolysis of the C2B domain of synaptotagmin IV. After incubating 4 µg of GST-Syt IV-C2BDelta 423-425 (upper panel) and -C2BDelta 423-425(AAA) (lower panel) in 10 mM Tris-HCl, pH 7.5, and 100 mM NaCl with 1 ng/µl trypsin for 0-30 min at 25 °C, the reactions were stopped by addition of SDS sample buffer and boiling for 3 min. Samples were then analyzed by 12.5% SDS-PAGE and staining with Coomassie Brilliant Blue R-250. GST-Syt IV-C2B (closed arrowheads) was rapidly cut into two pieces at the fusion site between GST (open arrowheads) and Syt IV-C2B (asterisk). Note that the Syt IV-C2BDelta 423-425 proteins were highly resistant to 1 ng/µl trypsin, whereas the mutant Syt IV-C2BDelta 423-425(AAA) proteins were degraded within 10 min. The results shown are representative of two independent experiments.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

We previously found that deletion of 17 amino acids C-terminal of Syt IV induced granular structures and prevented the Golgi localization of Syt IV (41). In this study we showed by electron microscopy that this granular structure is crystalloid ER (36, 37) and analyzed the mechanism of its induction by expression of Syts I-XI lacking the conserved WHXL motif in the C terminus. Crystalloid ER was found to be induced by following processes: (a) Mutation or deletion of the conserved amino acids in the beta -1 or beta -8 strand (e.g. GE/DL/I in the beta -1 strand or WHXL in the beta -8 strand; see Fig. 3B) in the C2 domain destabilizes one of the four-stranded beta -sheets (i.e. anti-parallel pairing of the N-terminal beta -1 strand and the C-terminal beta -8 strand), preventing the mutant proteins from folding correctly. Misfolding of the C2B domain lacking the WHXL motif was confirmed by limited proteolysis (Fig. 7). Because anti-parallel pairing of other beta -sheets occurred between adjacent beta -3 and beta -4 or beta -6 and beta -7 strands (57), we speculate that mutations or deletions in the beta -sheets formed by the N-terminal beta -1 strand and the C-terminal beta -8 strand add a most striking effect to C2 domain structure. (b) The resulting malfolded proteins are correctly inserted into the ER (showing type I membrane topology) but then are not transported to the Golgi (Fig. 6) and accumulate in the ER. Accumulation of the malfolded proteins in the ER induces the expression of BiP, one of the ER stress proteins, which are known to be induced by accumulation of malfolded proteins and to be present in stable complexes in the malfolded proteins (61, 62). Consistent with this, Syt IVDelta C proteins colocalized with BiP in the crystalloid ER (Fig. 1, E-G, arrows). Because the cytoplasmic domain of Syts I-XI lacking the WHXL motif (Syt-cytoDelta C) was expressed in the cytosol, and its expression could not induce crystalloid ER (5, 43), malfolded proteins seem to be recognized only in the ER. (c) We previously proposed that crystalloid ER is formed by head-to-head association of malfolded molecules on apposed smooth ER membranes based on the results of an experiment using rat liver microsomal aldehyde dehydrogenase (37). It should be noted that the synaptotagmin family also shows Ca2+-independent oligomerization activity via around the spacer domain and/or fatty-acylated Cys cluster at the interface between the transmembrane and spacer domains, and disulfide bonding at the extracellular domain (17, 38-40, 59). Indeed, the expression of Syt IDelta spacer/Delta C proteins, which lack oligomerization activity, could not induce crystalloid ER (Fig. 4). Therefore, it is most likely that the ERs in which Syt Delta C proteins have accumulated associate with each other to form crystalloid ER as a result of the oligomerizing capacity of the Syt family.

Because the WHXL motif was first proposed to be an independent domain based on sequence comparisons with the C2A domain structure (4), many in vitro binding experiments investigating the C2B domain, including our own, have involved the use of recombinant C2B domains lacking the WHXL motif (i.e. beta -8 strand), as minimum C2B domains (25, 48, 63, 64, 66). Accordingly, some in vitro binding experiments on the C2B domain should be re-evaluated in terms of ligand binding specificity or ligand affinity. Indeed, we found that the C2B domain lacking the WHXL motif showed weaker Ca2+-dependent oligomerization activity in Syt VII than the wild-type protein (45) and found distinct inositol polyphosphate binding specificity in Syt II (24). Based on these findings, we suggest that differences in the length of the C terminus of the recombinant C2B domain, in addition to the impurity of recombinant proteins (67), are another important factor responsible for the contradictory results obtained in regard to the in vitro binding properties of the C2B domain (48, 65, 68-70).

Krasnov and Enikolopov (35) recently reported that mutation or deletion of the C terminus of Syt II prevented it from being transported to the tips of neurites where dense-core vesicles are abundant in nerve growth factor-differentiated PC12 cells, and they proposed that the WHXL motif is an active signal for targeting to the tips of neurites. However, our finding that the malfolded Syt Delta C proteins lacking the WHXL motif are retained in the ER provides strong evidence against this idea. We suggest that Syt IIDelta C proteins accumulate in the ER, are not transported to the Golgi, and, consequently, are not present in the dense-core vesicles derived from the TGN.

In conclusion, we have demonstrated that the WHXL motif functions as a protein interaction site (e.g. neurexins) as well as being important for proper folding of the C2B domain to stabilize anti-parallel beta -sheet formation between beta -1 and beta -8 strands. We propose that recombinant C2B domains that contain the entire C terminus should be used for in vitro binding experiments to avoid abnormal folding of the C2B domain, which is only evident in the ER of living cells.

    ACKNOWLEDGEMENTS

We thank Eiko Kanno, Chika Saegusa, and Yukie Ogata for technical assistance.

    FOOTNOTES

* This work was supported by grants from the Science and Technology Agency to Japan (to K. M.) and Grants 13780624 from the Ministry of Education, Science, and Culture of Japan (to M. F.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Laboratory for Developmental Neurobiology, Brain Science Institute, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan. Tel.: 81-48-467-9745; Fax: 81-48-467-9744; E-mail: mnfukuda@brain.riken.go.jp.

Published, JBC Papers in Press, August 30, 2001, DOI 10.1074/jbc.M106209200

    ABBREVIATIONS

The abbreviations used are: Syt(s), synaptotagmin(s); ER, endoplasmic reticulum; GST, glutathione S-transferase; HRP, horseradish peroxidase; PAGE, polyacrylamide gel electrophoresis; TGN, trans-Golgi network; BiP, immunoglobulin heavy chain binding protein.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Marquèze, B., Berton, F., and Seagar, M. (2000) Biochimie (Paris) 82, 409-420
2. Fukuda, M., and Mikoshiba, K. (1997) Bioessays 19, 593-603
3. Schiavo, G., Osborne, S. L., and Sgouros, J. G. (1998) Biochem. Biophys. Res. Commun. 248, 1-8
4. Südhof, T. C., and Rizo, J. (1996) Neuron 17, 379-388
5. Fukuda, M., Moreira, J. E., Liu, V., Sugimori, M., Mikoshiba, K., and Llinás, R. R. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 14715-14719
6. Mikoshiba, K., Fukuda, M., Moreira, J. E., Lewis, F. M. T., Sugimori, M., Niinobe, M., and Llinás, R. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 10703-10707
7. Mochida, S., Fukuda, M., Niinobe, M., Kobayashi, H., and Mikoshiba, K. (1997) Neuroscience 77, 937-943
8. Ohara-Imaizumi, M., Fukuda, M., Niinobe, M., Misonou, H., Ikeda, K., Murakami, T., Kawasaki, M., Mikoshiba, K., and Kumakura, K. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 287-291
9. Lang, J., Fukuda, M., Zhang, H., Mikoshiba, K., and Wollheim, C. B. (1997) EMBO J. 16, 5837-5846
10. Sugimori, M., Tong, C.-K., Fukuda, M., Moreira, J. E., Kojima, T., Mikoshiba, K., and Llinás, R. (1998) Neuroscience 86, 39-51
11. Thomas, D. M., and Elferink, L. A. (1998) J. Neurosci. 18, 3511-3520
12. Kabayama, H., Takei, K., Fukuda, M., Ibata, K., and Mikoshiba, K. (1999) Neuroscience 88, 999-1003
13. Detrait, E., Eddleman, C. S., Yoo, S., Fukuda, M., Nguyen, M. P., Bittner, G. D., and Fishman, H. M. (2000) J. Neurobiol. 44, 382-391
14. Detrait, E. R., Yoo, S., Eddleman, C. S., Fukuda, M., Bittner, G. D., and Fishman, H. M. (2000) J. Neurosci. Res. 62, 566-573
15. Fukuda, M., and Mikoshiba, K. (2000) Neurosci. Lett. 295, 33-36
16. Fukuda, M., Moreira, J. E., Lewis, F. M. T., Sugimori, M., Niinobe, M., Mikoshiba, K., and Llinás, R. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 10708-10712
17. von Poser, C., Zhang, J. Z., Mineo, C., Ding, W., Ying, Y., Südhof, T. C., and Anderson, R. G. W. (2000) J. Biol. Chem. 275, 30916-30924
18. Haucke, V., Wenk, M. R., Chapman, E. R., Farsad, K., and De Camilli, P. (2000) EMBO J. 19, 6011-6019
19. Bommert, K., Charlton, M. P., DeBello, W. M., Chin, G. J., Betz, H., and Augustine, G. J. (1993) Nature 363, 163-165
20. Fukuda, M., Kabayama, H., and Mikoshiba, K. (2000) FEBS Lett. 482, 269-272
21. Littleton, J. T., Bai, J., Vyas, B., Desai, R., Baltus, A. E., Garment, M. B., Carlson, S. D., Ganetzky, B., and Chapman, E. R. (2001) J. Neurosci. 21, 1421-1433
22. Desai, R. C., Vyas, B., Earles, C. A., Littleton, J. T., Kowalchyck, J. A., Martin, T. F. J., and Chapman, E. R. (2000) J. Cell Biol. 150, 1125-1136
23. Llinás, R., Sugimori, M., Lang, E. J., Morita, M., Fukuda, M., Niinobe, M., and Mikoshiba, K. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 12990-12993
24. Fukuda, M., Aruga, J., Niinobe, M., Aimoto, S., and Mikoshiba, K. (1994) J. Biol. Chem. 269, 29206-29211
25. Fukuda, M., Kojima, T., Aruga, J., Niinobe, M., and Mikoshiba, K. (1995) J. Biol. Chem. 270, 26523-26527
26. Geppert, M., Goda, Y., Hammer, R. E., Li, C., Rosahl, T. W., Stevens, C. F., and Südhof, T. C. (1994) Cell 79, 717-727
27. DiAntonio, A., Parfitt, K. D., and Schwarz, T. L. (1993) Cell 73, 1281-1290
28. Littleton, J. T., Stern, M., Schulze, K., Perin, M., and Bellen, H. J. (1993) Cell 74, 1125-1134
29. Nonet, M. L., Grundahl, K., Meyer, B. J., and Rand, J. B. (1993) Cell 73, 1291-1305
30. Jorgensen, E. M., Hartwieg, E., Schuske, K., Nonet, M. L., Jin, Y., and Horvitz, H. R. (1995) Nature 378, 196-199
31. Reist, N. E., Buchanan, J., Li, J., DiAntonio, A., Buxton, E. M., and Schwarz, T. L. (1998) J. Neurosci. 18, 7662-7673
32. Fernandez-Chacon, R., Konigstorfer, A., Gerber, S. H., Garcia, J., Matos, M. F., Stevens, C. F., Brose, N., Rizo, J., Rosenmund, C., and Südhof, T. C. (2001) Nature 410, 41-49
33. Fukuda, M., and Mikoshiba, K. (2001) Biochem. J. 354, 249-257
34. Lloyd, T. E., Verstreken, P., Ostrin, E. J., Phillippi, A., Lichtarge, O., and Bellen, H. J. (2000) Neuron 26, 45-50
35. Krasnov, P. A., and Enikolopov, G. (2000) J. Cell Sci. 113, 1389-1404
36. Pathak, R. K., Luskey, K. L., and Anderson, R. G. W (1986) J. Cell Biol. 102, 2158-2168
37. Yamamoto, A., Masaki, R., and Tashiro, Y. (1996) J. Cell Sci. 109, 1727-1738
38. Fukuda, M., Kanno, E., and Mikoshiba, K. (1999) J. Biol. Chem. 274, 31421-31427
39. Fukuda, M., and Mikoshiba, K. (2000) J. Biochem. (Tokyo) 128, 637-645
40. Fukuda, M., and Mikoshiba, K. (2000) J. Biol. Chem. 275, 28180-28185
41. Fukuda, M., Ibata, K., and Mikoshiba, K. (2001) J. Neurochem. 77, 730-740
42. Mizushima, S., and Nagata, S. (1990) Nucleic Acids Res. 18, 5332
43. Fukuda, M., and Mikoshiba, K. (1999) J. Biol. Chem. 274, 31428-31434
44. Ibata, K., Fukuda, M., Hamada, T., Kabayama, H., and Mikoshiba, K. (2000) J. Neurochem. 74, 518-526
45. Fukuda, M., and Mikoshiba, K. (2001) J. Biol. Chem. 276, 27670-27676
46. Smith, D. B., and Johnson, K. S. (1988) Gene 67, 31-40
47. Mizutani, A., Fukuda, M., Niinobe, M., and Mikoshiba, K. (1997) Biochem. Biophys. Res. Commun. 240, 128-131
48. Chapman, E. R., Desai, R. C., Davis, A. F., and Tornehl, C. K. (1998) J. Biol. Chem. 273, 32966-32972
49. Fukuda, M., and Mikoshiba, K. (2001) Biochem. Biophys. Res. Commun. 281, 1226-1233
50. Fukuda, M., Saegusa, C., and Mikoshiba, K. (2001) Biochem. Biophys. Res. Commun. 283, 513-519
51. Perin, M. S., Brose, N., Jahn, R., and Südhof, T. C. (1991) J. Biol. Chem. 266, 623-629
52. Petrenko, A. G., Perin, M. S., Davletov, B. A., Ushkaryov, Y. A., Geppert, M., and Südhof, T. C. (1991) Nature 353, 65-68
53. Hata, Y., Davletov, B., Petrenko, A. G., Jahn, R., and Südhof, T. C. (1993) Neuron 10, 307-315
54. Perin, M. S. (1996) Biochemistry 35, 13808-13816
55. Sutton, R. B., Ernst, J. A., and Brunger, A. T. (1999) J. Cell Biol. 147, 589-598
56. Ubach, J., Garcia, J., Nittler, M. P., Südhof, T. C., and Rizo, J. (1999) Nat. Cell Biol. 1, 106-111
57. Nalefski, E. A., and Falke, J. J. (1996) Protein Sci. 5, 2375-2390
58. Ishihara, N., Yamashina, S., Sakaguchi, M., Mihara, K., and Omura, T. (1995) J. Biochem. (Tokyo) 118, 397-404
59. Fukuda, M., Kanno, E., Ogata, Y., and Mikoshiba, K. (2001) J. Biol. Chem. 276, 40319-40325
60. Kida, Y., Sakaguchi, M., Fukuda, M., Mikoshiba, K., and Mihara, K. (2000) J. Cell Biol. 150, 719-730
61. Kozutsumi, Y., Segal, M., Normington, K., Gething, M. J., and Sambrook, J. (1988) Nature 332, 462-464
62. Lenny, N., and Green, M. (1991) J. Biol. Chem. 266, 20532-20537
63. Ibata, K., Fukuda, M., and Mikoshiba, K. (1998) J. Biol. Chem. 273, 12267-12273
64. Sugita, S., Hata, Y., and Südhof, T. C. (1996) J. Biol. Chem. 271, 1262-1265
65. Schiavo, G., Gmachl, M. J., Stenbeck, G., Söllner, T. H., and Rothman, J. E. (1995) Nature 378, 733-736
66. Kim, D. K., and Catterall, W. A. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 14782-14786
67. Ubach, J., Lao, Y., Fernandez, I., Arac, D., Südhof, T. C., and Rizo, J. (2001) Biochemistry 40, 5854-5860
68. Li, C., Ullrich, B., Zhang, J. Z., Anderson, R. G. W., Brose, N., and Südhof, T. C. (1995) Nature 375, 594-599
69. Chapman, E. R., Hanson, P. I., An, S., and Jahn, R. (1995) J. Biol. Chem. 270, 23667-23671
70. Schivell, A. E., Batchelor, R. H., and Bajjalieh, S. M. (1996) J. Biol. Chem. 271, 27770-27775


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
D. Lingwood, S. Schuck, C. Ferguson, M. J. Gerl, and K. Simons
Generation of Cubic Membranes by Controlled Homotypic Interaction of Membrane Proteins in the Endoplasmic Reticulum
J. Biol. Chem., May 1, 2009; 284(18): 12041 - 12048.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. R. Hinson and P. Cresswell
The N-terminal Amphipathic {alpha}-Helix of Viperin Mediates Localization to the Cytosolic Face of the Endoplasmic Reticulum and Inhibits Protein Secretion
J. Biol. Chem., February 13, 2009; 284(7): 4705 - 4712.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
B. Bhattacharya and P. Roy
Bluetongue Virus Outer Capsid Protein VP5 Interacts with Membrane Lipid Rafts via a SNARE Domain
J. Virol., November 1, 2008; 82(21): 10600 - 10612.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Amarilio, S. Ramachandran, H. Sabanay, and S. Lev
Differential Regulation of Endoplasmic Reticulum Structure through VAP-Nir Protein Interaction
J. Biol. Chem., February 18, 2005; 280(7): 5934 - 5944.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. R. Llinas, M. Sugimori, K. A. Moran, J. E. Moreira, and M. Fukuda
Vesicular reuptake inhibition by a synaptotagmin I C2B domain antibody at the squid giant synapse
PNAS, December 21, 2004; 101(51): 17855 - 17860.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Fukuda, E. Kanno, M. Satoh, C. Saegusa, and A. Yamamoto
Synaptotagmin VII Is Targeted to Dense-core Vesicles and Regulates Their Ca2+-dependent Exocytosis in PC12 Cells
J. Biol. Chem., December 10, 2004; 279(50): 52677 - 52684.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
M. Fukuda and A. Yamamoto
Effect of Forskolin on Synaptotagmin IV Protein Trafficking in PC12 Cells
J. Biochem., August 1, 2004; 136(2): 245 - 253.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Fukuda and T. Itoh
Slac2-a/Melanophilin Contains Multiple PEST-like Sequences That Are Highly Sensitive to Proteolysis
J. Biol. Chem., May 21, 2004; 279(21): 22314 - 22321.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
E. L. Snapp, R. S. Hegde, M. Francolini, F. Lombardo, S. Colombo, E. Pedrazzini, N. Borgese, and J. Lippincott-Schwartz
Formation of stacked ER cisternae by low affinity protein interactions
J. Cell Biol., October 27, 2003; 163(2): 257 - 269.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
M. Fukuda
Molecular Cloning, Expression, and Characterization of a Novel Class of Synaptotagmin (Syt XIV) Conserved from Drosophila to Humans
J. Biochem., May 1, 2003; 133(5): 641 - 649.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Fukuda, E. Kanno, Y. Ogata, C. Saegusa, T. Kim, Y. P. Loh, and A. Yamamoto
Nerve Growth Factor-dependent Sorting of Synaptotagmin IV Protein to Mature Dense-core Vesicles That Undergo Calcium-dependent Exocytosis in PC12 Cells
J. Biol. Chem., January 24, 2003; 278(5): 3220 - 3226.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Fukuda
Synaptotagmin-like Protein (Slp) Homology Domain 1 of Slac2-a/Melanophilin Is a Critical Determinant of GTP-dependent Specific Binding to Rab27A
J. Biol. Chem., October 11, 2002; 277(42): 40118 - 40124.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Fukuda
Vesicle-associated Membrane Protein-2/Synaptobrevin Binding to Synaptotagmin I Promotes O-Glycosylation of Synaptotagmin I
J. Biol. Chem., August 9, 2002; 277(33): 30351 - 30358.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Saegusa, M. Fukuda, and K. Mikoshiba
Synaptotagmin V Is Targeted to Dense-core Vesicles That Undergo Calcium-dependent Exocytosis in PC12 Cells
J. Biol. Chem., June 28, 2002; 277(27): 24499 - 24505.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/44/41112    most recent
M106209200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fukuda, M.
Right arrow Articles by Mikoshiba, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fukuda, M.
Right arrow Articles by Mikoshiba, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement